ChiCTR-INR-16008407
尚未开始
/
/
/
2016-05-03
/
/
Periodontal disease
單盲平衡隨機對照臨床試驗- 比較以牙周內窺鏡輔助的牙根清創術或以開放翻瓣清創手術處理牙周骨下缺陷的效果差別
單盲平衡隨機對照臨床試驗- 比較以牙周內窺鏡輔助的牙根清創術或以開放翻瓣清創手術處理牙周骨下缺陷的效果差別
1. Study Objectives 1.1. Primary Objective 1.1.1. To compare the primary clinical outcome variable, i.e. change of clinical attachment level, and secondary clinical outcome variables at primary surgical site. i.e. periodontal defects with periodontal pocket depth ≥6mm and an intra-bony component ≥3mm, treated by Periodontal Endoscope Assisted Root Surface Debridement or conventional periodontal surgery - Open Flap Debridement. 1.2. Secondary Objectives 1.2.1. To compare the clinical outcome variables at secondary surgical site, i.e. periodontal defects with periodontal pocket depth ≤5mm, treated by Periodontal Endoscope Assisted Root Surface Debridement or conventional periodontal surgery - Open Flap Debridement. 1.2.2. To compare the patient-centered outcomes, during intra-operative and recovery period, from Periodontal Endoscope Assisted Root Surface Debridement and conventional periodontal surgery - Open Flap Debridement. 1.2.3. To compare the time required for Periodontal Endoscope Assisted Root Surface Debridement and conventional periodontal surgery - Open Flap Debridement.
随机平行对照
治疗新技术
5.3. Randomization Procedure 5.3.1. Therapy assignment A set of randomization code with Block Randomization (Random Block size 2 and 4) Sequentially Numbered, Opaque Sealed Envelopes (SNOSE) will be prepared for therapy assignment (Test or Control Therapy). The envelope will be opened by the RA after baseline parameters meas
/
General Research Fund, University Grant Council, HKSAR
/
22
/
2016-07-01
2018-06-30
/
5.12.1. Inclusion Criteria 5.12.1.1. Chronic Periodontitis patients; 5.12.1.2. At least 1 tooth presented with 1 site with >5mm PPD and ≥6mm CAL, with ≥3mm intra-osseous defect presented on paralleling periapical radiographs; 5.12.1.3. Presence of at least one periodontally stable tooth with PPD≤3mm both anterior and posterior to the defined surgical site; 5.12.1.4. Good Oral Hygiene, with Full Mouth Plaque Score ≤30% at baseline and with good plaque control at proposed surgical field;;
请登录查看5.12.2. Exclusion Criteria 5.12.2.1. Pre-study period 5.12.2.1.1. Any systemic condition which prevents following the study protocol; 5.12.2.1.2. Any systemic condition which may affect healing outcomes of patients, e.g. uncontrolled or poorly controlled diabetes, unstable or life-threatening conditions or those requiring antibiotic prophylaxis; 5.12.2.1.3. Patients under long term analgesic medication; 5.12.2.1.4. Self-reported pregnancy; 5.12.2.1.5. Systemic antimicrobial therapy within 3 months; 5.12.2.1.6. Tooth with hopeless prognosis or questionable prognosis associated with endodontic lesions; 5.12.2.1.7. Any factors which prohibit regular performance of plaque control around surgical sites; 5.12.2.1.8. Inadequate oral hygiene with Full Mouth Plaque Score >30%;
请登录查看Prince Philip Dental Hospital
/
Prince Philip Dental Hospital的其他临床试验
香港大學牙醫學院的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

